Picture of Annexin Pharmaceuticals AB (publ) logo

ANNX — Annexin Pharmaceuticals AB (publ) News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Annexin Publishes Positive Results In Co's Phase 1-Study

Sept 14 (Reuters) - Annexin Pharmaceuticals AB (publ)
 ANNX.ST :
    * POSITIVE RESULTS IN CO'S PHASE 1-STUDY
    * DRUG CANDIDATE ANXV WAS WELL TOLERATED

Source text for Eikon:  ID:nWkr3mhlws 
Further company coverage:  ANNX.ST 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Annexin Pharmaceuticals AB (publ)

See all news